X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (14) 14
humans (11) 11
adult (9) 9
article (9) 9
female (9) 9
pharmacology & pharmacy (8) 8
clinical trials (6) 6
hiv infections - drug therapy (6) 6
infectious diseases (6) 6
prevention (6) 6
adherence (5) 5
hiv infection (5) 5
hiv infections - prevention & control (5) 5
human immunodeficiency virus--hiv (5) 5
male (5) 5
tuberculosis - drug therapy (5) 5
compliance (4) 4
drug therapy (4) 4
health aspects (4) 4
hiv (4) 4
hiv infections - complications (4) 4
hiv prevention (4) 4
medicine & public health (4) 4
medicine, general & internal (4) 4
microbicides (4) 4
middle aged (4) 4
south-africa (4) 4
abridged index medicus (3) 3
africa (3) 3
anti-hiv agents - therapeutic use (3) 3
antimicrobial agents (3) 3
antiretroviral drugs (3) 3
antitubercular agents - therapeutic use (3) 3
care and treatment (3) 3
double-blind method (3) 3
drug therapy, combination (3) 3
electronic monitoring (3) 3
fluoroquinolones - therapeutic use (3) 3
follow-up studies (3) 3
health psychology (3) 3
moxifloxacin (3) 3
pharmacokinetics (3) 3
population pharmacokinetics (3) 3
public health (3) 3
public, environmental & occupational health (3) 3
pulmonary tuberculosis (3) 3
research (3) 3
social sciences, biomedical (3) 3
tuberculosis (3) 3
usage (3) 3
administration, intravaginal (2) 2
adolescent (2) 2
aids-related opportunistic infections - drug therapy (2) 2
anti-hiv agents - administration & dosage (2) 2
anti-infective agents (2) 2
anti-infective agents - administration & dosage (2) 2
anti-retroviral agents - administration & dosage (2) 2
antiretroviral prophylaxis (2) 2
antiretroviral therapy (2) 2
antitubercular agents - adverse effects (2) 2
cd4 lymphocyte count (2) 2
challenges (2) 2
clinical outcomes (2) 2
clinical-trials (2) 2
coitus (2) 2
disease prevention (2) 2
dosage and administration (2) 2
double-blind (2) 2
drug administration schedule (2) 2
drug delivery systems - instrumentation (2) 2
drug dosages (2) 2
efavirenz (2) 2
feasibility (2) 2
feasibility studies (2) 2
fluoroquinolones - pharmacokinetics (2) 2
gels (2) 2
hiv infections - epidemiology (2) 2
hiv infections - mortality (2) 2
incidence (2) 2
infected patients (2) 2
infection (2) 2
kaplan-meier estimate (2) 2
model (2) 2
multidrug-resistant tuberculosis (2) 2
p-glycoprotein (2) 2
patient compliance - statistics & numerical data (2) 2
pharmacogenetics (2) 2
pharmacology (2) 2
pilot projects (2) 2
plasma-concentrations (2) 2
polymorphisms (2) 2
preexposure prophylaxis (2) 2
pyrazinamide (2) 2
resistance (2) 2
reverse transcriptase inhibitors - administration & dosage (2) 2
reverse transcriptase inhibitors - adverse effects (2) 2
rifampicin (2) 2
rifampin - therapeutic use (2) 2
risk factors (2) 2
tenofovir (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 10/2011, Volume 365, Issue 16, pp. 1492 - 1501
Journal Article
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ISSN 1058-4838, 01/2020, Volume 70, Issue 1, pp. 90 - 98
The substitution of moxifloxacin for ethambutol produced promising results for improved tuberculosis treatment outcomes. We conducted an open-label, randomized... 
Journal Article
The Journal of Clinical Pharmacology, ISSN 0091-2700, 11/2017, Volume 57, Issue 11, pp. 1369 - 1386
Journal Article
PHARMACOGENOMICS, ISSN 1462-2416, 03/2019, Volume 20, Issue 4, pp. 225 - 240
Aim: We report the prevalence and effect of genetic variability on pharmacokinetic parameters of isoniazid and rifampicin. Materials & methods: Genotypes for... 
IMPORTANT PHARMACOGENE INFORMATION | rifampicin | isoniazid | pyrazinamide | tuberculosis | MODEL | PREGNANE-X-RECEPTOR | FAILURE | POLYMORPHISMS | SERUM DRUG CONCENTRATIONS | POPULATION PHARMACOKINETICS | pharmacokinetics | PHARMACOLOGY & PHARMACY | COHORT | MOXIFLOXACIN | pharmacogenetics
Journal Article
by Prabhakaran, Dorairaj and Anand, Shuchi and Watkins, David and Gaziano, Thomas and Wu, Yangfeng and Mbanya, Jean Claude and Nugent, Rachel and Ajay, Vamadevan S and Afshin, Ashkan and Adler, Alma and Ali, Mohammed K and Bateman, Eric and Bettger, Janet and Bonow, Robert O and Brouwer, Elizabeth and Bukhman, Gene and Bull, Fiona and Burney, Peter and Capewell, Simon and Chan, Juliana and Chandrasekar, Eeshwar K and Chen, Jie and Criqui, Michael H and Dirks, John and Dugani, Sagar B and Engelgau, Michael and El Nahas, Meguid and Fall, Caroline HD and Feigin, Valery and Fowkes, F Gerald R and Glassman, Amanda and Goenka, Shifalika and Gupta, Rajeev and Hasan, Babar and Hersch, Fred and Hu, Frank and Huffman, Mark D and Jabbour, Samer and Jarvis, Deborah and Jeemon, Panniyammakal and Joshi, Rohina and Kamano, Jemima H and Kengne, Andre Pascal and Kudesia, Preeti and Kumar, R Krishna and Kumaran, Kalyanaraman and Lambert, Estelle V and Lee, Edward S and Li, Chaoyun and Luo, Rong and Magee, Matthew and Malik, Vasanti S and Marin-Neto, J Antonio and Marks, Guy and Mayosi, Bongani and McGuire, Helen and Micha, Renata and Miranda, J Jaime and Montoya, Pablo Aschner and Moran, Andrew E and Mozaffarian, Dariush and Naicker, Saraladevi and Naidoo, Nadraj G and Narayan, KM Venkat and Nikolic, Irina and O'Donnell, Martin and Onen, Churchill and Osmond, Clive and Patel, Anushka and Perez-Padilla, Rogelio and Poulter, Neil and Pratt, Michael and Rabkin, Miriam and Rajan, Vikram and Rassi, Anis and Rawal, Ishita and Remuzzi, Giuseppe and Riella, Miguel and Roth, Greg A and Roy, Ambuj and Rubinstein, Adolfo and Sakuma, Yuna and Sampson, Uchechukwu KA and Siegel, Karen R and Sliwa, Karen and Suhrcke, Marc and Tandon, Nikhil and Thomas, Bernadette and Vaca, Claudia and Vedanthan, Rajesh and Verguet, Stéphane and Webb, Michael and Weber, Mary Beth and Whitsel, Laurie and Wong, Gary and Yan, Lijing L and Yancy, Clyde W and Zhang, Ping and Zhao, Dong and Zhu, Yishan and Dis Control Priorities Cardiovasc and Disease Control Priorities-3 Cardiovascular, Respiratory, and Related Disorders Author Group
The Lancet, ISSN 0140-6736, 03/2018, Volume 391, Issue 10126, pp. 1224 - 1236
Journal Article
Pharmacogenomics and Personalized Medicine, ISSN 1178-7066, 08/2017, Volume 10, pp. 233 - 234
Anushka Naidoo,1 Kogieleum Naidoo,1,2 Veron Ramsuran,3 Millidhashni Reddy,1 Nesri Padayatchi1,2 1Centre for the AIDS Programme of Research in South Africa,... 
PHARMACOLOGY & PHARMACY | ATAZANAVIR HYPERBILIRUBINEMIA UGT1A1
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 2017, Volume 72, Issue 5, pp. 1441 - 1449
Objectives: We compared the pharmacokinetics of moxifloxacin during rifampicin co-treatment or when dosed alone in African patients with drug-susceptible... 
INFECTIOUS DISEASES | TREATMENT OUTCOMES | QUANTIFICATION | MICROBIOLOGY | OPEN-LABEL | MODEL | POLYMORPHISM | 8-METHOXYFLUOROQUINOLONE | PLASMA-CONCENTRATIONS | POPULATION PHARMACOKINETICS | MULTIDRUG-RESISTANT TUBERCULOSIS | PYRAZINAMIDE | PHARMACOLOGY & PHARMACY | Tuberculosis, Pulmonary - microbiology | Tuberculosis, Pulmonary - metabolism | Antibiotics, Antitubercular - adverse effects | Rifampin - blood | Coinfection - drug therapy | Humans | Male | Tuberculosis, Pulmonary - drug therapy | Fluoroquinolones - pharmacokinetics | Reverse Transcriptase Inhibitors - administration & dosage | Tuberculosis, Pulmonary - complications | Anti-HIV Agents - administration & dosage | Reverse Transcriptase Inhibitors - adverse effects | Rifampin - adverse effects | Drug Interactions | Adult | Anti-HIV Agents - therapeutic use | Benzoxazines - blood | Female | Rifampin - therapeutic use | Reverse Transcriptase Inhibitors - therapeutic use | Rifampin - administration & dosage | Drug Therapy, Combination | Antibiotics, Antitubercular - administration & dosage | Fluoroquinolones - administration & dosage | Antibiotics, Antitubercular - pharmacokinetics | Benzoxazines - administration & dosage | HIV Infections - virology | Africa | Fluoroquinolones - therapeutic use | Coinfection - virology | Benzoxazines - therapeutic use | Coinfection - microbiology | Fluoroquinolones - blood | Antibiotics, Antitubercular - therapeutic use | HIV Infections - complications | HIV Infections - drug therapy | Original Research
Journal Article
AIDS and Behavior, ISSN 1090-7165, 2/2013, Volume 17, Issue 2, pp. 640 - 648
Journal Article
Journal Article